There were ugly scenes in Cardiff ahead of the Sky Bet Championship Severnside derby match between Cardiff City and Bristol City.

Vince Neil's private jet was coming from Austin, Texas, when it crashed at Scottsdale Airport in Arizona killing the pilot ...

Some of the 183 Palestinian prisoners released by Israel arrived in Gaza's southern city of Khan Younis via Red Cross buses. NBC News' Yasmin Vossoughian reports on the latest conditions inside ...

Police were called to The Horsefair in Bristol at 18.05 GMT A pedestrian has been taken to hospital after being hit by a bus. Avon and Somerset Police said officers were called to The Horsefair ...

With Bristol emerging as a key point of contention, issues around bus route cancellations, the shortcomings of on-demand transport schemes, and calls for greater local control over public services ...

Florida students will be breathing a bit easier this year thanks to the deployment of 13 new Blue Bird electric school buses — some of which will be replacing diesel buses that have been service ...

Fare evasion in the New York City transit system is on the decline, although 45% of all city bus riders still aren’t paying for their trips, according to new MTA figures. Data released Wednesday ...

Our Gunners are set to commence their Adobe Women's FA Cup journey with a fourth-round clash against Bristol City Women this Wednesday evening. The fixture, which was postponed due to a frozen pitch ...

Two drivers ticketed by school bus cameras in the Town of Hempstead have filed a lawsuit seeking to throw out all tickets issued since the program launched in 2022. The complaint filed Friday ...

SINGAPORE – From mid-2026, six driverless buses will ply public bus routes in Marina Bay and Shenton Way, as well as one-north in Buona Vista, as part of a pilot by the Land Transport Authority ...

Analyst Terence Flynn of Morgan Stanley maintained a Sell rating on Bristol-Myers Squibb (BMY – Research Report), retaining the price target of $39.00. Terence Flynn’s rating is based on ...

David Risinger’s rating is based on the impressive launch performance of Bristol-Myers Squibb’s Cobenfy, which is showing strong sales momentum since its introduction for schizophrenia treatment.